Understanding Your First Steps With Each Treatment
Wegovy and Mounjaro Doses: Starting Your Treatment Safely
When comparing Wegovy and Mounjaro doses for your first prescription, understanding each treatment's starting approach is essential for success. Wegovy begins with a gentle 0.25mg dose for weeks 1-4, designed to help your body adjust gradually to the GLP-1 receptor agonist effects. This careful starter dose minimises potential side effects whilst allowing you to experience the appetite-reducing benefits progressively. Mounjaro takes a different approach, starting at 2.5mg weekly as it combines both GIP and GLP-1 receptor agonism in a dual-action formula.
The key difference in these Wegovy and Mounjaro doses reflects their distinct mechanisms and clinical development programmes. Wegovy's 16-week escalation follows extensive STEP trial protocols, moving from 0.25mg through 0.5mg, 1mg, 1.7mg, to the 2.4mg maintenance dose. Mounjaro's schedule progresses from 2.5mg to 5mg at 4 weeks, with potential increases to 7.5mg, 10mg, 12.5mg, or 15mg based on individual response. Both treatments require clinical assessment and ongoing prescriber supervision as prescription-only medicines. Your prescriber will help determine which starting approach aligns with your medical history and treatment goals.
Pricing and Value: Wegovy and Mounjaro Doses Comparison
Understanding the cost implications of Wegovy and Mounjaro doses helps you plan your treatment budget effectively. Wegovy's 0.25mg starter dose costs £79.99 with discount code FIRST40 applied at checkout for new customers, whilst returning customers use code DOSE25. The escalation continues with 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and maintenance 2.4mg at £209.99. EverydayMeds offers convenient bundle options like the Intro Duo (0.25mg & 0.5mg) for £169.99, ensuring seamless progression through your first 8 weeks.
Mounjaro pricing follows a different structure reflecting its distinct dosing schedule and dual-action mechanism. Both Wegovy and Mounjaro doses are available through our streamlined ordering process with the same clinical standards and next-day delivery service. Bundle options provide added convenience for maintaining consistent supply without frequent reordering. All prices include VAT and represent the final cost after applying appropriate discount codes at checkout, with no hidden fees or subscription requirements affecting your treatment costs.
Clinical Evidence Behind Wegovy and Mounjaro Doses
The starting doses for both treatments stem from extensive clinical trial programmes demonstrating their effectiveness alongside reduced-calorie diets and increased physical activity. Wegovy's dosing schedule was established through the STEP trial programme, including STEP 1 which showed participants achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The gradual dose escalation proved essential for tolerability whilst maintaining efficacy throughout the study period.
Mounjaro's starting approach emerged from the SURMOUNT clinical programme, demonstrating the effectiveness of its dual GIP/GLP-1 receptor agonism mechanism. Both sets of trials emphasised that these Wegovy and Mounjaro doses work optimally when combined with comprehensive lifestyle interventions rather than as standalone treatments. Individual results may vary, and both treatments require ongoing medical supervision to ensure appropriate dose adjustments and monitoring for potential side effects.
How Wegovy Works: Understanding the GLP-1 Mechanism
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormone to support weight management. When you inject your weekly dose, semaglutide activates GLP-1 receptors in your brain's appetite control centres, potentially reducing feelings of hunger and increasing satiety after meals. This mechanism may help you feel satisfied with smaller portions and experience fewer food cravings throughout the day. The treatment also slows gastric emptying, which can contribute to prolonged feelings of fullness after eating. Starting with the 0.25mg dose allows your body to adjust gradually to these effects, reducing the likelihood of gastrointestinal side effects whilst building tolerance for higher therapeutic doses. This careful approach ensures you can continue treatment successfully through the complete 16-week escalation schedule.
Your EverydayMeds Ordering Process
Starting either Wegovy or Mounjaro through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, designed to gather essential medical information for prescriber review. Our qualified prescribers evaluate your submission within 3 working days (or 24 hours with express review), ensuring each prescription meets clinical safety standards before approval. Once approved, your medication ships via next-day delivery using temperature-controlled cold-chain packaging to maintain effectiveness throughout transit. We provide detailed injection guidance, storage instructions, and ongoing support to help you succeed with your chosen treatment. Our GPhC-registered pharmacy (#9012878) ensures full regulatory compliance whilst maintaining the convenience and discretion you expect from modern healthcare delivery.
Storage and Practical Considerations
Proper storage significantly impacts the effectiveness of both Wegovy and Mounjaro doses throughout your treatment. Wegovy pens require refrigeration at 2-8°C before first use but offer excellent travel flexibility with up to 6 weeks of room temperature storage below 30°C once removed from the fridge. The FlexTouch pen design provides reliable dose delivery with clear dose tracking, essential for following the precise escalation schedule. Mounjaro requires similar refrigeration but only maintains potency for 21 days at room temperature, making Wegovy more convenient for extended travel. Both treatments use pre-filled pens with hidden needles to minimise injection anxiety. Never freeze either medication, and always check the solution appears clear and colourless before injection to ensure medication integrity.
Choosing Between Wegovy and Mounjaro Doses: Key Differences
The fundamental difference between Wegovy and Mounjaro doses lies in their starting intensity and escalation philosophy. Wegovy's ultra-gentle 0.25mg beginning allows highly sensitive individuals to build tolerance gradually, particularly beneficial for those concerned about potential nausea or gastrointestinal adjustment. This conservative approach extends the escalation period but often results in better long-term adherence. Mounjaro's 2.5mg starting dose reflects confidence in its dual-action tolerability profile, potentially reaching therapeutic effects more quickly for suitable candidates.
Your medical history, previous experiences with similar medications, lifestyle factors, and personal preferences all influence which approach suits you best. Some patients prefer Wegovy's methodical progression, whilst others appreciate Mounjaro's different mechanism and dosing strategy. Both represent evidence-based approaches to weight management, and neither is inherently superior to the other. Your prescriber will consider your individual circumstances to recommend the most appropriate starting approach for your specific situation.
Start Your Treatment With Confidence Today
Beginning your weight management journey with either Wegovy or Mounjaro represents an important step towards better health, supported by proven clinical evidence and professional medical guidance. EverydayMeds simplifies access to both treatments through our streamlined prescription service, competitive pricing with transparent discount codes, and reliable next-day delivery throughout the UK. New customers can apply code FIRST40 at checkout, whilst returning customers use DOSE25 to access our competitive pricing structure. Our clinical team remains available to support your treatment success, ensuring you receive ongoing guidance alongside your medication supply. Whether you choose Wegovy's gentle escalation or Mounjaro's dual-action approach, we're here to support your journey with expert pharmaceutical care and reliable service you can trust.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
